Clarke Futch co-founded HealthCare Royalty Partners, growing it into a drug-royalty investor with over $5 billion.
Clarke Futch co-founded HealthCare Royalty Partners, growing it into a drug-royalty investor with over $5 billion. The firm invests in revenue streams generated by FDA-approved biopharma assets. Futch primarily focuses on commercial-stage or late-stage development products, deploying $25 million to $200 million per royalty acquisition.
Full founder directory · Investor directory · Company funding database · Fundraising library